Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and ...

There is increased risk for major gastrointestinal bleeding with edoxaban vs VKA therapy in patients with atrial fibrillation following TAVR.

Evidence-based recommendations on transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation. This involves implanting a replacement valve inside the faulty native valve ...

Transcatheter aortic valve implantation (TAVI) can be used in the NHS while more evidence is generated to treat native aortic valve regurgitation when surgical aortic valve replacement (SAVR) is not ...

JenaValve announced today that it began patient enrollment in the ARTIST study evaluating its Trilogy TAVR system.

Abbott is doubling down on the structural heart space as it aims to gain ground in valve replacements following the recent ...

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial ...

Sutureless Aortic Valve & Stentless Valves Stentless Valves In order to improve hemodynamics, especially in a small annulus (21–19 mm), stentless bioprosthesis has been developed. [13–16 ...

The global transcatheter heart valve replacement (TAVR) market is estimated to be valued at USD 8.18 billion in 2025 and is projected to reach USD 32.82 billion by 2035, registering a compound annual ...

Transcatheter Aortic Valve Implantation Transcatheter aortic valve implantation (TAVI) is an expanding therapeutic option for high-risk patients that are not considered to be suitable candidates ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...